Page de couverture de EKU Podcast: The evolving role of GLP1-RA in obesity

EKU Podcast: The evolving role of GLP1-RA in obesity

EKU Podcast: The evolving role of GLP1-RA in obesity

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

 Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of drugs initially developed to treat type 2 diabetes and are now becoming more widely used for obesity. They work by mimicking the actions of the GLP-1 hormone, which is released by the gut after eating. GPs will be used to prescribing them for type 2 diabetes, but less so for obesity.
In this podcast, Dr Thomas Round discusses the evolving role of GLP1-RA in obesity, the benefits and potential side effects, the role of the GP, and the latest NICE guidance in this area with Dr Stephanie DiGiorgio, an urgent care GP with a specialist interest in obesity.

Ce que les auditeurs disent de EKU Podcast: The evolving role of GLP1-RA in obesity

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.

Évaluations sur Audible.ca

Évaluations sur Amazon.ca
Il n'y a pas encore de critiques pour ce titre.